Glucose markers in healthy and diabetic bitches in different stages of the oestral cycle by Mared, Malin
Sveriges lantbruksuniversitet
Fakulteten för Veterinärmedicin och husdjursvetenskap
Institutionen för kliniska vetenskaper (KV)
Glucose markers in healthy and diabetic bitches 
in different stages of the oestral cycle
Malin Mared
Uppsala
2010
Examensarbete inom veterinärprogrammet
ISSN 1652-8697
Examensarbete 2010:13
2SLU
Sveriges Lantbruksuniversitet
Glukosmarkörer hos friska och diabetessjuka tikar
i olika löpstadier
Malin Mared
Handledare:Tove Fall, Institutionen för kliniska vetenskaper
Examinator: Bernt Jones, Institutionen för kliniska vetenskaper
Examensarbete inom veterinärprogrammet, Uppsala 2009
Fakulteten för Veterinärmedicin och husdjursvetenskap
Institutionen för kliniska vetenskaper
Kurskod: EX0239, Nivå X, 30hp
Nyckelord: diabetes, HbA1c, gråhund, östralcykel, insulin, progesteron, glukos
Online publication of this work: http://epsilon.slu.se
ISSN 1652-8697
Examensarbete 2010:13
3Table of Contents
ABSTRACT.......................................................................................................................... 5
SAMMANFATTNING ......................................................................................................... 6
INTRODUCTION................................................................................................................. 7
BACKGROUND INFORMATION....................................................................................... 7
Blood glucose.................................................................................................. 7
Hormones increasing blood glucose ........................................................................... 8
Insulin.......................................................................................................................... 8
The oestral cycle and progesterone .................................................................. 8
Diabetes Mellitus in Dogs................................................................................ 8
Pathophysiology.......................................................................................................... 8
Classification of canine diabetes mellitus ................................................................... 9
Progesterone-related diabetes ................................................................................... 9
Age and breed predisposition ................................................................................... 10
Diagnostic methods ........................................................................................10
Blood glucose ............................................................................................................ 10
Fructosamine............................................................................................................. 11
Insulin/C-peptide.......................................................................................................11
Progesterone.............................................................................................................12
HbA1c............................................................................................................12
Formation of HbA1c ..................................................................................................12
HbA1c in human medicine ........................................................................................ 12
Factor interfering with HbA1c results in humans ..................................................... 12
Previous HbA1c measurements in dogs.................................................................... 13
MATERIALS AND METHODS......................................................................................... 13
Dogs...............................................................................................................13
Group 1 ..................................................................................................................... 14
Group 2 ..................................................................................................................... 14
Group 3 ..................................................................................................................... 14
The samples....................................................................................................15
4Analysing the results ......................................................................................16
Measuring HbA1c with Cholestech GDX Analysis.........................................16
RESULTS ........................................................................................................................... 16
Glucose markers by breed...............................................................................16
Comparison by phase in oestrous cycle...........................................................16
Comparison healthy dogs to diabetic dogs ......................................................17
DISCUSSION ..................................................................................................................... 17
Are glucose markers values higher for dogs in dioestrous? .............................17
Is HbA1c reliable to use for canine medicine? ................................................17
Comparison with earlier results ................................................................................ 17
Standardization ......................................................................................................... 18
Between run variation .............................................................................................. 18
Overlap...................................................................................................................... 18
Human methods for dog use .................................................................................... 19
The effect of storage on HbA1c ................................................................................ 19
Lack of hematocrite values ....................................................................................... 19
Fructosamine or HbA1c? ................................................................................19
CONCLUSIONS................................................................................................................. 20
AKNOWLEDGEMENTS ................................................................................................... 20
FIGURE 1. STUDY RESULTS........................................................................................... 21
REFERENCES.................................................................................................................... 22
5ABSTRACT
The female dog has a unique reproductive endocrinology, with high levels of 
progesterone throughout the 70-day long luteal phase. In this project, markers of 
glucose metabolism were studied and compared from the aspects of breed group 
and time in oestral cycle. The parameters studied were: glucose, insulin, 
progesterone, fructosamine and the newly introduced analysis of HbA1c. Hba1c 
was also further evaluated and discussed as a diagnostic tool in canine medicine. 
No differences in terms of glucose markers were found between a group of pure-
breed dogs of various breeds compared to a group of dogs with high risk of 
dioestrus diabetes, namely the Norwegian and Swedish elkhounds.
No differences were found between the two sample occasions, anoestrus and 
dioestrus, concluding that there is no need for relating test results to the time of 
the oestrous cycle in middle-aged intact female dogs. 
There were statistically significant higher values of all glucose markers in diabetic 
dogs than in non-diabetic dogs. When it came to HbA1c, however, there was a 
larger overlap between the two groups, compared to fructosamine. The HbA1c 
analysis was easy to perform, but was found to have a low precision. It was not 
possible to compare the results of HbA1c with other studies, since there is no 
agreement of a standardized method. The author therefore concludes that if 
HbA1c is to be used in veterinary medicine, reference values for the specific 
laboratory and analytic method needs to be set up. 
6SAMMANFATTNING
Tikens reproduktionsendokrinologi är unik i sitt slag i och med de höga 
progesteronvärden som kvarstår under hela lutealfasen. I denna studie jämfördes 
glukosmarkörer mellan två olika rasgrupper samt utifrån olika stadier av 
östralcykeln. De markörer som inkluderades i studien var glukos, insulin, 
progesteron, fruktosamin samt HbA1c. HbA1c utvärderades också vidare som ett 
diagnostiskt hjälpmedel inom veterinärmedicinen. 
När en grupp hundar med förhöjd risk att utveckla diabetes (grå- och jämthundar)
jämfördes med en grupp av hundar av blandade raser hittades inga skillnader i 
nivån på någon av glukosmarkörerna.
Inga skillnader hittades heller då prover från anöstrus jämfördes med prover från 
diöstrus, vilket leder till slutsatsen att fasen i östralcykeln ej behöver beaktas vid 
tolkning av provresultat. 
Signifikanta skillnader återfanns hos samtliga glukosmarkörer då diabetessjuka 
hundar jämfördes med friska hundar. Vad gäller HbA1c var det dock många 
diabetessjuka som befann sig inom samma intervall som de friska hundarna. 
Dessutom gick det inte att jämföra dessa resultat med de från tidigare studier, då
HbA1c-diagnostiken ej ännu är standardiserad inom veterinärmedicinen. 
Författaren anser därför att om HbA1c ska användas som ett diagnostiskt 
hjälpmedel för diabetessjuka hundar, måste metoden standardiseras för att 
meningsfulla resultat ska kunna erhållas.
7INTRODUCTION
The syndrome diabetes mellitus, hereafter referred to as diabetes, has for a long 
time been known as a frequently occurring disease in humans as well as dogs and 
other companion animals. In Sweden, 1,2 % of all dogs are estimated to develop 
diabetes mellitus before the age of twelve years. The Swedish and Norwegian 
elkhounds are breeds with elevated risk of developing diabetes, and in which 
almost only females are affected by the disease (Fall, 2009).
Concerning the techniques for diagnosing diabetes and monitoring the treatment, 
there has been a huge development since the time when diabetes was diagnosed 
through a sweet taste of the urine. One very important instrument for diagnosing 
and monitoring treatment of diabetes in humans has for a long time been the 
measurement of glycosylated hemoglobin molecules, HbA1c. These are formed 
by an irreversible non-enzymatic binding of glucose to haemoglobin, and the 
percentage of glycosylated molecules increases if the patient has hyperglycemia. 
HbA1c reflects the glycemia, during the life of hemoglobin, which is 
approximately 120 days in humans and dogs.
For mainly economical and practical reasons, HbA1c has not been used in dogs 
until recently. However, this has now become possible through the development 
of less expensive instruments. Earlier tests has shown that these analytical 
instruments may be possible to use in veterinary diagnostics, but that still more
needs to learn about normal values of HbA1c in dogs. 
One of the aspects of canine diabetes not extensively tested is whether the 
reproductive hormonal cycle of bitches affects HbA1c and other glucose markers, 
something that this study aims to investigate. We hypothesize that dioestral 
bitches have higher values of glucose, fructosamine and HbA1c than anoestral 
bitches, due to the antagonistic insulin effect of progesterone and possibly of 
mammary-derived growth hormone. The purpose of this project is to:
a) Test the hypothesis that glucose markers are elevated in dioestrus compared to 
other phases of the oestral cycle
b) Investigate if there are differences to be found in glucose markers levels 
between a high-risk diabetes breed for dioestrus diabetes (elkhounds) compared to 
a mixed dog population
c) Further evaluate the use of HbA1c in dogs
BACKGROUND INFORMATION
Blood glucose
Glucose is a monosaccharide, which is used by the body as an energy source and 
as a precursor in the production of lipids and proteins. Glucose is used as the
prime energy source in most cells (Johnson, 2008). Glucose is supplied to the 
body by food intake, and is also synthesized in organs such as the liver.
8Normal blood glucose value is essential to the well-being of an animal. There are 
mainly two hormones, insulin and glucagon, produced by alpha and beta cells in 
the endocrine pancreas, which acts together to maintain normal values of blood 
glucose. The release of these hormones is controlled by the glucose sensing 
system in the alpha and beta cells.
Hormones increasing blood glucose
Glucagon is a catabolic hormone released from alpha cells when blood glucose is 
low. The effect of glucagon is to increase blood glucose by glycogenolys and 
glyconeogenes. Other hormones also act to increase blood sugar, namely cortisol, 
growth hormone, epinephrine and norepinephrine (Johnson, 2008). These 
hormones both act to increase the secretion of glucose from the liver, but also 
diminish the effect of insulin in target cells. 
Insulin
Insulin is secreted by beta cells in response to increasing blood glucose levels. 
This hormone has the opposite effect in the body compared to glucagon, as it 
enables the intake of glucose into cells and stimulates the storage of glucose in 
forms of glycogen and fat (Johnson, 2008). 
The oestral cycle and progesterone
The oestral cycle of a bitch consist of 4 different phases: prooestrus, oestrus, 
dioestrus and anoestrus. Progesterone is a hormone which is important to maintain
a pregnancy. During the oestral cycle, progesterone values change dramatically. 
The concentration of this hormone is rising during prooestrus and oestrus to reach 
its maximal level approximately three weeks after the onset of dioestrus. During 
anoestrus the bitch is hormonally inactive considering reproductive hormones and 
the values of progesterone are low (Concannon et al, 1975). 
The unique thing in bitches compared to females of other species is the 
maintenance of high progesterone values during dioestrus, independent of whether 
the bitch is pregnant or not (Eigenmann et al, 1983). Concannon et al (1973) 
found no differences in maximal progesterone values in dioestrus between 
pregnant and non-pregnant bitches. In most other species, the progesterone values 
decreases as soon as the body has recognized that there is no pregnancy to 
maintain. 
Diabetes Mellitus in Dogs
Pathophysiology
Canine diabetes mellitus is an endocrine disorder, in which the dog has defects in 
insulin secretion, insulin action, or both. A normal insulin production and 
response enables glucose molecules in the blood to enter into the body tissue cells. 
A lack of insulin or insulin response results in high concentrations of blood 
glucose, but low levels in intracellular glucose. As a result of the hyperglycemia, 
glucose is excreted in the urine causing polydipsia and polyuria. The lack of 
glucose in tissues causes increased gluconeogenesis and glycogenolys, which 
gives further rise to the blood glucose, as well as causing weight loss and 
9polyphagia. When the insulin/glucagon ratio is low, the liver will start to form 
ketones as an alternative source of energy, eventually leading to ketoacidosis. 
Classification of canine diabetes mellitus
Canine diabetes can result from a wide range of causes resulting in either insulin 
deficiency or insulin resistance. There are several different ways used to classify 
diabetes into different groups, for example based on whether they require insulin 
treatment or not, or whether the disease results from insulin deficiency or insulin 
resistance (Catchpole et al, 2005). However, according to the latest research, these 
classification methods are not concerned to be satisfactory for dogs as both will 
leave a large proportion of individuals unclassified due to the fact that the 
different groups overlap. Almost all dogs with diabetes eventually will need 
insulin treatment, making it hard to distinguish a non-insulin dependent form from 
an insulin dependent one and insulin resistance diabetes often will turn into 
insulin deficiency diabetes, resulting in the same problem. In her doctoral thesis, 
Tove Fall therefore proposed a new classification scheme for diabetes based upon 
the cause of disease (Fall, 2009). The main groups of classification in this new 
scheme can be reviewed in table 1.
Table 1. Classification of Diabetes Mellitus (Fall, 2009)
Juvenile diabetes mellitus
Progesterone-related
Secondary to pancreatitis
Endocrine tumours
Iatrogenic
Immune-mediated diabetes mellitus
Idiopathic diabetes mellitus
Progesterone-related diabetes
The main concern of this project is progesterone-related diabetes which may be 
divided into gestational and dioestrus diabetes. This type of diabetes arises when a 
patient has enough insulin-secreting beta cells to cover their day to day life, but 
who has no residual capacity and hence could not handle if the tissue gets a bit 
more resistant to insulin, e.g. by raised levels of progesterone due to the iatrogenic 
supply or during the dioestrus phase in bitches. 
In intact bitches, diabetes often is diagnosed during dioestrus (Catchpole et al, 
2005). Progesterone can give rise to an insulin resistance, through a post binding 
defect (Ryan, 1988). The insulin resistance leads to chronic hyperglycemia which 
damages the insulin-producing cells, resulting in insulin deficiency (Fall, 2009).
According to Rijnberk, high endogenous progesterone levels may also result in 
high levels of mammary gland-derived growth hormone which may enhance the 
insulin resistance (2003).
Eigenmann et al showed that ovariohysterectomy improved glucose tolerance by 
lowering levels of GH (1983). In a study from 2005, it was stated that the 
response to insulin decreased with approximately 1/3 (35%) by iatrogenic supply 
of progesterone (Batista, 1978). It would therefore be expected that dogs in the 
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end of dioestrus have higher values of fructosamine and Hba1c levels than 
anoestrous dogs.
In Sweden, dioestrus diabetes accounts for the majority (60%) of all diabetes 
cases diagnosed in female dogs.
Age and breed predisposition
Diabetes may occur in any dog, the disease is, however, shown in several studies
to be more frequently occurring in females than in males, in older dogs than in 
younger, and in some breeds more than others. According to a Swedish study of 
180,000 dogs, the Australian terrier has an incidence rate of 183 cases per 10,000 
dog years at risk, while the incidence for Golden Retrievers turned out to be 0 
cases per 10 000 years at risk (Fall, 2008). 
In the study by Fall in 2008, Swedish elkhounds were among the four breeds that 
were most commonly affected by diabetes and Norwegian elkhounds were in the 
middle risk range. What was most notable with these two breeds, however, was 
that almost only intact female elkhounds were diagnosed with diabetes. The 
proportion of intact females of the total amount of diabetes cases in these breeds 
were 96% in Swedish and 100% in Norwegian elkhounds. Looking at the 
proportion of females in diabetes cases of all breeds, this was calculated to 72%. 
In 2009, Wallberg found that 96% of all diabetic elkhounds debuted during 
dioestrus. However, this was not related to a higher progesterone level in 
elkhounds than in normal dogs.  
The mean age of onset of diabetes in the total dog population is 8.6 years, and 
somewhat lower in Swedish elkhounds; 7.8 years, (Fall, 2007).
Diagnostic methods
The suspicion of diabetes in a dog should arise if all or some of the classic signs 
(polyuria, polydipsia, polyphagia, weight loss) are shown. Different diagnostic 
tests are discussed below.
Blood glucose
A high blood glucose level could indicate diabetes mellitus, but the level is 
constantly altering and a high level may indicate either short-term physical stress, 
recent intake of food or exaltation as well as disease. Davison et al (2003) has 
concluded that to diagnose diabetes by glucose measurements, there should be a 
minimum of 16 tests taken to establish the true mean blood glucose value. A 
device that is inserted subcutaneously which measures blood glucose continuously 
has been evaluated and found useful in a hospital setting. Continuous blood 
glucose measuring is, however, laborious and expensive. This is why the need for 
an instrument that will measure glucose levels over longer periods arises. For this 
purpose, fructosamine is almost exclusively used in dogs in Sweden today, while 
HbA1c is extensively used in human diabetic patients.
A glucose tolerance test is done to evaluate a patient that is only mildly 
hyperglycemic with varying state of glucosuria. The test is done by infusing the 
dog with glucose intravenously and then measuring the levels of glucose 
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continuously during the following hour. In a non-diabetic patient, the glucose 
values returns to normal within this hour, but in a diabetic patient the high values 
persists after this first hour.
Fructosamine
Fructosamine is formed when serum proteins are glycated, which they do 
continuously even in healthy dogs, but in a larger proportion when values of 
glucose and/or proteins in the blood is elevated. The reaction is irreversible and 
high values indicate high levels of blood glucose during the latest 1-3 weeks 
before sampling, based on the lifespan of albumin (Jensen, 1992).
Values of fructosamine are not fluctuating like blood glucose in response to stress 
or intake of food, and therefore serve as a good compliment to measuring of 
single blood glucose values. However, high values of fructosamine can arise 
during other circumstances than diabetes, e.g. if not blood glucose but blood
proteins are above a normal level, for example in a dehydrated animal (Reusch et 
al, 2001). Fructosamines can also be falsely high in dogs with a slow metabolism 
of proteins, e.g. hypothyroid patients, which was proved in several studies, among 
others one by Reusch et al in 2002. Reusch explained the elevation in 
fructosamine with the longer time that proteins are in the blood and may react 
with amino acids. Fructosamine value can also be falsely low due to 
hypoproteinemia, hyperlipidemia and azotemia (Reusch, 2001). 
Insulin/C-peptide
According to Nelson et al (2004), measurement of insulin is only recommended in 
a dog with suspicion of secondary diabetes, to detect high insulin levels in 
combination with hyperglycemia. The disadvantage of measuring insulin as a 
diabetes marker is that it can vary due to for example amount of time from latest 
intake of food. It can also be affected by certain types of drugs. This problem can 
be bypassed by measuring insulin in fasted animals or after a controlled 
stimulation with glucagon or arginine (Fall, 2008). Higher insulin values than 
normal indicates secondary diabetes mellitus while lower values indicate a 
primary insulin deficiency or secondary diabetes turned into an insulin deficiency. 
Low insulin values can occur due to glucotoxicity in a patient with secondary 
diabetes.
If glucagon is injected intravenously into a normal dog, this will give a short rise 
in insulin blood concentrations. However, if injected into a diabetic dog, there will 
be no rise in insulin concentration, since there is a deficiency in the production of 
insulin. (Montgomery et al, 1996). The test is often used in humans. According to 
several authors, instead of measuring insulin after glucagon injection, one of its 
precursor units called C-peptide is preferred (Montgomery et al 1996, Fall 2000), 
since insulin treatment will not affect the amount of this peptide. The test is 
carried out by injecting 1 mg glucagon intravenously and then measure either 
insulin or c-peptide before and 10 minutes after glucagon administration. Since 
basic levels of insulin and c-peptide is low in patients that lack insulin production 
and high in patients who have sufficient insulin production, but a deficiency in 
insulin respondance, this test can help to separate different kinds of diabetes from 
one another (Fall, 2007).
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Progesterone 
If an intact bitch is diagnosed with diabetes mellitus, progesterone can be 
measured to see if the dog is in luteal phase or not.
HbA1c
Formation of HbA1c
Hemoglobin is an important part of the blood, as it serves as the oxygen carrier in 
the red blood cells. A proportion of the total amount of hemoglobin molecules in 
the blood is always bound to glucose, as a result of the chemical properties of 
these two blood constituents. Glucose can bind to hemoglobin in the red blood 
cell in any time of its lifespan by a non-enzymatic reaction (Bunn et al, 1978), and 
once formed the only way for the HbA1c to dissolve is when the red blood cell is 
taken out of circulation (Peacock, 1984). The binding is irreversible and the 
proportion of hemoglobin molecules bound to glucose will rise in relation to 
increasing amounts of blood glucose. There are many different types of 
glycosylated hemoglobin molecules, based on where in the hemoglobin molecule 
the glucose is situated. HbA1c is a measurable fraction of glycosylated 
hemoglobin, in which the N-terminal of the B-Chain of the hemoglobin molecule 
is glycosylated. Such a glycosylation alters the properties of the hemoglobin 
molecule more than glycosylation at other sites, why these molecules are the best 
for analyzing. (Peacock ,1984). The lifespan of a red blood cell is up to 120 days, 
why HbA1c levels reflects the medium blood glucose values for up to 3 months 
back in time. Marca et al studied the effect of acute hyperglycemia on HbA1c and 
found that such a thing will not affect the levels of neither HbA1c nor 
fructosamine values (2000c).
HbA1c in human medicine
HbaA1c has been used in human diagnostics since 1977 (John et al, 2007). In a 
review article from 1984, a human medicine expert writes that glycosylated 
hemoglobin “offer the best available means of assessing diabetic control” 
(Peacock, 1984). When first introduced, the analysis was based on differences in 
charge between glycated and non-glycated hemoglobin molecules, but since 1981 
there also has been test based on structural differences between the two (John et 
al, 2007). When first analyzing HbA1c in humans, the results differed and were 
not comparable between different laboratories, why standardization methods have 
been taken into operation. The normal value of HbA1c with these standardized 
methods in humans is 4-6%. In an article in Clinical Endocrinology and 
metabolism, Saudek et al found that HbA1c was preferred among doctors as a 
diabetic instrument for several reasons; the results are now standardized and 
reliable and it does not alter after intake of food, it reflects glucose values over a 
long time and it is uncommon that factors other than glucose will interfere with 
the HbA1c measurements (2008). 
Factor interfering with HbA1c results in humans
In humans, it is found that HbA1c values could differ between groups of people 
based on origination. In one study, it was found that Americans from Africa had 
higher HbA1c values than rest of the American population. This is an interesting 
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finding, as this study is going to explore if there is differences between different 
groups of dog breeds. 
HbA1c can be falsely low in patient with erythrocytes of a relatively shorter 
lifespan; as the younger the blood cells, the less they are exposed to a persistent 
hyperglycemia (Peacock, 1984). Examples of such conditions are hemolytic 
anemia or bleeding. Saudek et al (2008) therefore suggests that HbA1c should not 
be used in patients with anemia. Oppositely, if erythrocyte lifespan is prolonged, 
HbA1c will become falsely elevated due to a longer exposure of red blood cells to 
hyperglycemia. An example of this condition is in patients which have undergone 
splenectomy. 
HbA1c analysis may also be disturbed by certain vitamins, iron deficiency and 
hemoglobinopathies (Saudek et al, 2008). It also depends on methods of 
determination as well as calibration of the assay (Hetil,  2009). High levels of 
HbA1c leading to a diabetes mellitus diagnosis, should therefore be confirmed 
with other types of diagnostic testing (Saudek et al, 2008).
Previous HbA1c measurements in dogs
The use of HbA1c in canine samples has not been investigated thoroughly, but 
there are a number of studies reported. A study of HbA1c was carried out by 
Catchpole et al in 2008 in which the results were that there was a good correlation 
between high fructosamine values and high HbA1c values, that diabetic dogs had 
statistically significant higher values of HbA1c than non-diabetics, but that there 
were no difference in HbA1c values according to if the dog had a untreated 
diabetes or was under treatment with insulin. The normal value of HbA1c was 
established at 3,7 to 5,6 per cent. Diabetic dogs had HbA1c values between 4,9 
and 13 per cent. However, in an earlier study by Davison, Catchpole et al, it was 
found that the correlation between HbA1c and fructosamine was not so good
(2002). In this study the normal values somewhat different from the 2008 study, 
with a median normal value of 2,1-3,7 %, while diabetics had values ranging from 
2,5-7 %. The same method (boronate affinity chromatography) for measuring 
HbA1c as in this study was used in the study from 2002, while another method 
was used by Catchpole in 2008. 
In 2000, a test measuring HbA1c in 86 dogs was carried out in and there was no 
difference in HbA1c level found between different age groups of dogs or between 
males and females. In the study differences where found between the different 
phases in the oestrous cycle, but the values were still in the reference interval 
given in the study why authors of the article concluded that there would be no 
need for taking the test at a certain time of the oestral cycle. (Marca & Loste, 
2000)
MATERIALS AND METHODS
Dogs
Three different groups of dogs were included in the study. One group of clinically 
healthy elkhounds, one group of clinically healthy pure-bred dogs of various
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breeds and one group of dioestrous diabetes pure-breed dogs of various breeds. 
The dogs in group 1 and 2 were sampled by the same veterinarian and frozen in -
20°C for 0-6 months, before sent on ice to SLU where it was stored in at -70°C. 
The inclusion criteria for the different groups were as follows: 
Group 1
Included in this group are clinically healthy female intact dog, minimum 4 years 
old, from any part of Sweden. Breeds included were Swedish or Norwegian 
elkhounds. One of the dogs in this group turned diabetic during the study and was 
consequently excluded from further analysis. 
Group 2
Included in this group are clinically healthy female intact dogs, minimum 4 years 
old, from any part of Sweden. The dog could belong to any pure-bred dog except
elkhounds (Swedish or Norwegian), Beagles or Border Collies. 
Blood samples from Group 1 and 2 were taken at two sample occasions, once 
during anoestrus and once during dioestrus. The dioestrus test was taken 6-8 
weeks after the end of oestrus, and the anoestral test was taken at least 3 months 
after heat. All groups in group 1 and 2 were fasting at the times of sampling.
Group 3
In this group there are dogs of any breed diagnosed with diabetes in the 
progesterone phase (1-3 months after end of heat). Diagnosis was based on 
clinical signs, glucosuria and high blood glucose and fructosamine levels. No 
treatment with insulin was started at the date of sampling. Blood samples from 
this group of dogs were taken at the day of diagnosis, or in some cases a couple of 
days later, but still before onset of treatment. 12 dogs were found to match the 
criteria. The samples were taken between the years of 2005 and 2008 and stored at 
-70°C. Fasting status was unknown.
The breeds and ages of the dogs are shown in Table 2.
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The samples
From all dogs blood samples in both EDTA and serum test tubes were taken. 
Serum was separated from the blood clot within one hour. Sera and whole blood 
was stored in freezer until analysis.
Table 2. Groups of dogs included in the study
The measurements
Glucose, fructosamine, insulin and progesterone were analysed at the University 
Animal Hospital Laboratory at the Swedish University of Agricultural Sciences 
(SLU). The methods used and the reference values can be seen in table 3. HbA1c 
was measured on by the author by the method described beneath. 
Value Method Name of assay Reference value
Fructosamine Colometric assay ABX Pentra 
Fructosamine
200-400 µmol/l
Insulin Sandwich ELISA Mercodia Insulin 
ELISA
5-25 mU/L
Glucose glucose hexokinase 
method
Thermo Clinical 
Labsystems
3,5-6,0 mmol/l
Progesterone enzyme immunoassay Immunlite 2000 
Progesterone
Anoestrus: <1 nmol/L
Dioestrus: High
Table 3: Reference values of glucose markers
N breeds age (median, 
range)
Weeks after estrus for 
sample 1 (dioestrus)
Group 1 24 8 Norwegian elkhounds
16 Swedish elkhounds
6.0, 4.1-10.1 4.4, 2.1-7.6
Group 2 18 2 Rough-haired collie
1 Dalmatian
1 Finnish lapphund
1 Finnish Spitz
1 Finnish hound
2 German Shepherd
5 Golden Retriever
1 Hamilton hound
1 Hovawart
1 Labrador retriever
1 Papillon
1 Tervueren
6.1, 3.8-12.2 4.0, 2.0-5.4
Group 3 12 1 Alaskan husky
2 Australian terrier
1 Bichon frisée
2 Mixed breed
3 Border collie
1 Borzoi
1 Hälleforshund
1 Leonberger
10.0, 7.0-11.9 4.7, 1.3-10.0
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Analysing the results
All results were collected into a Microsoft Excel Spreadsheet and analyzed in 
JMP and Graphpad Prism. Wilcoxon rank sum test was used to assess differences
among groups. Box plots were drawn to illustrate the results. 
Measuring HbA1c with Cholestech GDX Analysis
For the measurement of HbA1c in this study, a device called Cholestech GDX 
Analyze was used. The Cholestech GDX analyzer uses EDTA blood and analyzes 
it through a method called boronate affinity chromatography. The measurement is 
carried out in three steps, in which the first step lyses the blood which makes the 
glycosylated hemoglobin can attach so called boronate affinity resin. After 40 
seconds the sample is poured into the cartridge test tunnel where the 
unglycosylated hemoglobin molecules will be trapped into a special chamber, 
while the glycosylated hemoglobin molecules will sink to the bottom of the tunnel 
as they are bound to the boronate affinity resin. In step 2, a washing solution is 
poured onto this bottom fragment and in the third step a solution that finishes the 
binding between the resin and the glycosylated molecules is added, so that the 
glycosylcated hemoglobin molecules can be measured. The machine will then 
divide the result of the glycosylated molecules with the total (glycosylated and 
nonglycosylated) hemoglobin amount. The result is then mathematically corrected 
and finally the machine shows the percentage of hemoglobin molecules that are 
glycosylated. Before and after the measurements where done, the machine was 
evaluated using human blood with a pre-known glycosylated hemoglobin fraction. 
In this study, the machine showed good correspondence.
All blood samples were measured twice with the same procedure, and a mean 
value was calculated from the two received values. In cases where the value from 
measurement number one and two differed more than 0.3%, HbA1c was 
calculated a third time. The mean value was then calculated from the two values 
closest to one another, out of these three times. If all three measured values 
differed more than 0.3 % from one another, the tested sample was excluded from 
the calculations.
RESULTS
The results are shown in Figure 1.
Glucose markers by breed
There were no statistically significant differences in levels of glucose, insulin or 
fructosamine. HbA1c or progesterone between healthy elkhounds (group 2) and 
dogs of other breeds (group 1). The lack of differences was consistent during both 
oestrus and dioestrus. 
Comparison by phase in oestrous cycle
Progesterone was statistically higher in dioestrus than in anoestrus. This was an 
expected but still an important finding since it gives evidence of that the dogs 
really were in dioestrus at the time of one sample and in anoestrus at the time of 
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the other sample. There were no statistically significant differences to be found 
concerning insulin, glucose, fructosamine and HbA1c in any of the breed groups, 
when comparing anoestrus with dioestrus. 
Comparison healthy dogs to diabetic dogs
There was a statistically significant difference in HbA1c (p<0.001), glucose 
(p<0.001) and fructosamine (p<0.001) values in dioestrous diabetics compared to 
clinically heathy dogs in dioestrus. There was no difference in insulin or 
progesterone levels between the two groups. 
DISCUSSION
Are glucose markers values higher for dogs in dioestrous?
The hypothesis of this work was that the insulin resistance caused by progesterone 
and possibly growth hormone would yield higher values of HbA1c and 
fructosamine during dioestrus than during anoestrus. There were no such 
differences to support our hypothesis seen in this study. The result may have been 
different if all dogs were sampled later in dioestrus, since HbA1c and 
fructosamine are formed continuously during high levels of blood glucose. The 
lack of difference, however, makes diagnosing diabetes by HbA1c and 
fructosamine measurement less complicated, since it doesn’t form a need for 
different reference intervals for dioestrus dogs. 
Is HbA1c reliable to use for canine medicine?
Comparison with earlier results
In this comparison, elkhounds and dogs of other breeds, as well as anoestrus and 
dioestrus HbA1c values are calculated together, since no differences were seen 
between the groups. The mean value of all HbA1c measurements for healthy dogs
in this study was 4,8 (range from 3,6-9,4), which corresponds well to the result of 
Catchpole (2008) (median value of reference in his study interval 4,7). However 8 
out of 80 HbA1c measurements of healthy dogs would be higher than the set 
reference interval of Catchpole without showing any signs of diabetes and 1 
would be lower than the reference interval. Compared to Davison’s study in 2002, 
the values measured in this study was much higher and only 1 out of 80 
measurements on healthy dogs was inside the Davison’s interval, pointing out the 
need for different reference interval with different devices. 
When it comes to the diabetic patients, the correspondence to Catchpoles studies 
is not as good, as in his study diabetic patients had Hba1c values with a median 
value of 9,3 and in this study no diabetic patient had such a high value. HbA1c 
values in diabetics in this study ranging from 4,8 %to 6,7 %, which more 
resembles the results of Davison, where diabetic patients ranged from 2,5-7 %. 
One reason for the lack of comparable result may be that most studies are done in 
hospitalized animals, while this study was done in outward animals. Catchpole et 
al concluded that diseased animals have a higher glucocorticoid level, higher 
blood glucose and supposingly higher HbA1c values than other dogs, but that 
there are also other studies with opposite results (2008).
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The dogs in this study were all newly diagnosed, which may have caused lower 
HbA1c than in dogs that had had the disease for longer time. 
Standardization
It seems to be inappropriate to compare HbA1c measurements between different 
laboratories and measurement methods, since large variations can be seen. This 
fact was supported by Marca & Loste, when they pointed out the lack of extensive 
use of HbA1c measurements in dogs as a reason for this (2000). When HbA1c 
first started to be used in human medicine, there were similar problems with lack 
of meaningful implementation of HbA1c measurements (Little et al, 2001). 
Conclusions were drawn that the materials used in the assays were prepared in 
different ways, i.e. for calibration and hence gave different results (Little et al, 
2001), and the American Diabetes Society was negative to using HbA1c for 
diagnostics (Saudek et al, 2003). In America, a standardization program was 
begun, which would make results comparable between different laboratories. 
Referring to the background information of this assay, HbA1c measurements are 
now preferred among many medical doctors. It is in the authors’ strong belief that 
if HbA1c measurements are to be used in veterinary medicine, the assay would 
benefit from a standardization program for canine samples. 
Between run variation
In this study, the HbA1c value was measured twice, and if the difference between 
these two times were more than 0,3%, the same test was run a third time. This 
happened 30 out of 92 times (33%), according to the authors’ belief showing a 
low precision for the use of the machine for canine blood samples.
It can be declared that the poor between run precision is a disadvantage of the 
method, findings supported by Marca et Loste in 2000, although they used another 
method. Marca et Loste proposed better calibration of the assay as a solution to 
the problem. 
Overlap
HbA1c values of diabetics had a median value of 5.9 while non-diabetics in mixed 
breeds had a median value of 4.7, leading to a significant difference between the 
two groups. However, 5 out of the 12 dogs (42%) diagnosed with diabetes had 
values of HbA1c that would also fit into the interval of the non-diabetic dogs.
Many authors who investigated HbA1c in dogs found that HbA1c is significantly 
elevated in diabetics compared to non-diabetics (Marca et al, 2000; Catchpole et 
al, 2008: Davison et al, 2002)
However, several authors have also found a degree of overlap between 
glycosylated hemoglobin values of healthy and diabetic dogs (Davison et al 2002;
Delack & Stogdale, 1983). This was also found in this study. In the study of 
Delack & Stogdale, all diabetic animals were in the reference range. That study 
was measuring total HbA1 and not only HbA1c. However, HbA1c constitutes 
approximately 80 % of the total HbA1, why these results are considered 
interesting.
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Human methods for dog use
According to the manufacturer of the Cholestech GDX analyzer, values of HbA1c 
would be reliable between 4 and 15 %. 8 out of 92 (9%) of values are below this 
range, none above. 
As far as the author knows, there is no HbA1c measuring method especially made 
for dogs. The similarities between human HbA1c and canine HbA1c has been 
clarified by several authors. However, Davison et al suggest that there might be 
differences in the physiochemical properties between these two molecules (2002). 
The author believes that this may interfere with the accuracy of all methods used 
for HbA1c measurements in dogs. Davison is also pointing out the need for an 
algorithm in HbA1c measurements evaluated especially for dogs (2002). Marca et 
Loste found that when using canine blood in HbA1c measurements, the assay had 
to be calibrated far more often than human blood using the same method (2000), 
which supports the idea of important differences between human and canine 
HbA1c. 
The effect of storage on HbA1c
One theory that the author has for explaining the somewhat different HbA1c 
values achieved in this study is that the storage of the blood resulted in changes 
that resulted in faulty measurements. The blood in the study was first stored in -20 
degrees for a couple of months, followed by storage in -70 degrees, It has been 
shown that levels of fructosamine can change statistically during storage of canine 
blood and that these changes may be of clinical importance (Thoresen et al, 1995). 
There is one notice of that HbA1c is stable in -20 degrees for 77 days (Marca et 
al, 2000) and another study where no changes were seen after storage in 4 degrees 
for 7 days (Easley, 1986). However, no further information about this has been 
found, for which reason the storage factor cannot be completely disregarded.
Lack of hematocrite values
According to the Cholestech GDX manufacturer, the hematocrite concentrations 
that would be appropriate for the analysis should range from 30 to 60 % in human 
blood. There was no measurements of hematocrite done in this study, which could 
be a source of errors, since it has been declared that dogs with anemia should be 
excluded from measurements of HbA1c (Haberer 1998). However, in 2000, 
Marca et al found that the differences in HbA1c between anemic and non-anemic 
dogs were not significant. (Marca et al, 2000, CJVR). Furthermore, the dogs in 
group 1 and 2 of this study were all healthy dogs without clinical symptoms, and 
the influence of hemtocrite could probably therefore be minimized. 
Fructosamine or HbA1c?
Whether to diagnose and monitor diabetes best with fructosamine or HbA1c 
remains to be further elevated. Loste & Marca concluded that the main difference 
is the time aspect, since HbA1c reflects glucose levels during a longer time than 
does fructosamine (2000). In this and other studies there is an extensive degree of 
overlap in HbA1c values of healthy and dioestrous dogs, but there has also been 
reports on the same problem with fructosamine. Reusch et al (2001) found that 
some diabetic cats and dogs have fructosamine values in the reference interval, 
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mainly because of lack of elevated blood glucose during a longer time, or due to 
the earlier explained changes associated with other concurrent diseases. Patients 
with such hypoproteinemia, hyperproteinamia and azotemia should not be sample 
for fructosamine (Reusch, 2001). In the same way, it can be argued that patients 
with for example anemia or hemoglobinopathy should not be sampled for HbA1c.
CONCLUSIONS
Concerning the main question in study, whether dioestral bitches have higher 
markers of glucose than anoestral bitches, no significant difference between the 
two groups were found. 
This is an important finding, since if HbA1c is to be used in diabetic dogs, it states 
that there will be no need for a different reference interval for cycling bitches than 
for other dogs. The result is consistent with the one for fructosamine, glucose and 
insulin, which also lacks significant differences between the two groups.
Throughout the study, no difference in either glucose, HbA1c, fructosamin, 
insulin or progesterone was found between elkhounds and other dogs, leading to 
no further answer why these dogs are more commonly affected by diabetes.
The evaluation of HbA1c measurements for canine samples in this study came to 
the conclusion that if to be used further in veterinary medicine, HbA1c 
measurement must be improved and standardized, since today, there are too many 
possible sources of errors which will prevent the method from yielding 
meaningful results. The problems found in this study is the lack of agreement 
between different studies, the high degree of overlap between healthy and diabetic 
dogs, the possibility that devices developed for human use may not be direct 
applicable to other species and the poor within-run precision. Although 
fructosamine measurements also suffer from errors, these are according to the 
authors’ conclusions fewer and the degree of overlap between healthy and 
diabetic animals is less extensive, why fructosamine are preferred until solutions 
to these problems are attained. When so, fructosamine and HbA1c may both be 
used, and choice between them could be done according to the existence 
concurrent diseases and the duration of glucose metabolism most wanted to be 
evaluated. 
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